维普中文期刊产品整合服务
54篇 您的检索式:作者名="Olsson SB"
    题名 作者 年代 出处 被引量
1阵发性心房颤动患者心房复极离散度的研究显示文摘目的 通过记录阵发性心房颤动 (房颤 )患者心房单相动作电位 (MAP) ,分析心房复极离散度与房颤发生的关系。方法 特发性阵发性房颤患者与无自发房颤病史的阵发性室上性心动过速患者各 1 5例 ,均接受心内电生理检查和 /或导管射频消融治疗。两根 MAP电极于右心房共取 4~ 1 0个不同部位进行同步的窦性心律基础刺激 (S1)及期前刺激 S2 时的 MAP记录。测量、计算心房复极离散度(RTd)及动作电位时限和局部冲动时间的离散度 (APDd、ATd)。 结果 窦性心律时房颤组最大 RTd显著大于对照组 (1 2 3 .69± 54.67) ms比 (64 .2 5± 2 3 .2 9) ms,(P<0 .0 1 )。其差异主要来源于 APDd(1 1 5.0 0± 4 6.90 ) ms比 (57.56± 3 3 .57) ms,(P<0 .0 1 ) ,ATd差异无显著性。随 S1、S2 的加入 ,各组局部激动时间和离散度逐渐增大 ,而动作电位时限逐渐缩短 ,且房颤组的这种改变程度显著大于对照组。在S1时无房颤发生 ,加入期前刺激时 ,大多数房颤组患者均多次诱发出短阵房颤。其诱发率及次数均显著高于对照组。 结论 研究结果表明 ,MAP记录技术是临床观察、分析心房复极离散度及其在阵发性房颤中的作用的较佳方法。心房复极离散度的增加是阵发性房颤发生的重要因素。李真 eva hertervig 袁世文 杨延宗 林治湖 olsson sb 1999中华心律失常学杂志1999,3,4:4
2心房颤动——当今面临的挑战显示文摘在过去数年里,临床和科撞方面对心房颤动(房颤)的关注明显增加,有关这一论题的出版物数量迅速、稳定的增长就是证明。虽然已有一些新方法治疗遮一心律失常一但大多数房颤患者仍然不得不忍受这一心律失常,包括其不良后果和症状,房颤无疑是虽迫切需要有更好治疗方法的一种心律失常。为了达到这一目的,就需要更深刻地认识房颤的机制.以便开发直接影响这一基础病理生理机制的治疗措施。Olsson SB Hansson A Hedin E Holm M Ingemansson M Johansson R Meurling C Pehrson S Roijer A Yuan S 方丕华 1997中华心律失常学杂志1997,1,1:3
3Atrioventricular conduction:A determinant for the manifestation of ventricular preexcitation in patients with Wolff-Parkinson-White syndrome显示文摘 Olsson SB Hertervig E 2001Clin Physiol2001,21,5:1
4Should we abandon the common practice of withholding oral antieoagulation in paroxys- mal atrial fibrillation显示文摘Nieuwlaat R Dinhl T Olsson SB 2008Eur Heart2008,29,7:1
5Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial 显示文摘Olsson SB Executive Steering Conmfittee of the SPORTIF III Investigators 2003Lancet2003,362,9397:1
6Conduction properties of accessory atrioventricular pathways: importmace of the accessory pathway location and normal atrioventricular conduction 显示文摘Liu S Yuan S Olsson SB 2003Scand Cardiovasc J2003,37,1:1
7Prevention of stroke in patients with atrial fibrillation 显示文摘Olsson SB Halperin JL 2005Sere in Vase Med2005,5,3:1
8Atrioventricular conduction: a determinant for the manifestation of ventricular preexcitation in patients with Wolff-Parkinson -White syndrome 显示文摘Liu S Olsson SB Hertervig E 2001Clin Physiol2001,21,5:1
9Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation : randomized controlled trial 显示文摘Olsson SB Executive Steering Committee on behalf of the SPORTIF Ⅲ Investigators 2003Lancet2003,362,:1
10Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF Ⅲ) randomised controlled trial显示文摘 2003Lancet2003,362,:1
11Prevention of stroke in patients with atrial fibrillation显示文摘Olsson SB Halperin JL 2005Semin Vase Med2005,5,3:1
12An unusual cause of taehycardiomyopathy: in- cessant atypical AV nodal reentrant tachycardia induced by 1 : 2 AV conduction 显示文摘Liu S Olsson SB 2001Europace2001,3,3:1
13Executive Steering Committee on behalf of the SPORTIF Ⅲ Investigators stroke prevention with the oral direct thrombin inhibitor SPORTIF Ⅱ investigators fibrillation (SPORTIF Ⅲ):random ised controlled trial 显示文摘Olsson SB 2003Chest2003,362,:1
14Atrial fibrillation-where do we stand today显示文摘Olsson SB 0,,:1
15Stroke prevention with oral direct thrombin inhibitor ximelagatrans compared with warfarin in patients with non-valvular atrial fibrillation( SPORTIF Ⅲ ) :randomized controlled trial显示文摘Olsson SB 2003Lancet2003,362,9397:1
16Monophasic action potenlials:concepts to parctication application显示文摘Yuan S lundgvist CB Olsson SB 1994J Cardiovasc Electropysiol1994,5,:1
17Should we abandon thecommon practice of withholding oral anticoagulation in paroxysmalatrial fibrillation 显示文摘Nieuwlaat R Dinh T Olsson SB 2008Eur Heart J2008,29,:1
18Stroke prevention with the oral direct thrombin inhibitor;SPORTIF Ⅱ Investigators fibrillation ( SPORTIF Ⅲ ) : randomised controlled trial显示文摘Olsson SB Executive Steeling Committee on hehalf of the SPORTIF Ⅲ Investi- gators 2003Lancet2003,362,:1
19Prevention of stroke in patients with atrial fibril-lation:department of cardiology,university hospital,lund,sweden 显示文摘Olsson SB Halperin JL 2005SeminVase Med2005,5,3:1
20Non-Invasive assessment of the atrial cycle length during chronic atrial fibrillation in man 显示文摘Holm M Olsson SB Johansson R 1996Circulation1996,94,8:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费